BlackRock Fund Advisors - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 61 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$13,878,000
+108.3%
901,143
+76.0%
0.00%
+200.0%
Q3 2016$6,661,000
+28.2%
511,978
+37.1%
0.00%0.0%
Q2 2016$5,194,000
+7.8%
373,419
+17.6%
0.00%0.0%
Q1 2016$4,817,000
-23.5%
317,504
-4.3%
0.00%0.0%
Q4 2015$6,293,000
+4.8%
331,758
+5.0%
0.00%
-50.0%
Q3 2015$6,002,000
-27.0%
315,878
-1.0%
0.00%0.0%
Q2 2015$8,222,000
+6927.4%
319,034
+8418.9%
0.00%
Q1 2015$117,000
-24.0%
3,745
-6.4%
0.00%
Q4 2014$154,0004,0010.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders